Senior Program Head

Role Summary

Senior Program Head

Responsibilities

• Drive the program's transformational vision, devise an adaptable strategy that anticipates future trends and challenges, and translate strategies into practical, impactful plans.
• Seek out and combine complex internal/external elements to inform business decision-making, identify key issues in complex scenarios, and ensure clarity.
• Embody an enterprise leader that works across the entire Novartis research-development-commercial continuum to understand the impact of decisions, the benefit of diverse perspective, and the power of our shared purpose.
• Deliver organization-wide impact through an understanding and respect for an evolving technological landscape, including knowing when and how to incorporate new tools into existing strategies while evolving ahead of anticipated capabilities (e.g., precision medicine, AI, blockchain, nanotechnology).

• The GPH has sole accountability of and responsibility to deliver enterprise value by defining the asset’s strategic vision, optimize life cycle management, and drive the integrated development plans to ensure successful regulatory and access outcomes.
• Leads the design of the Target Product Profile (TPP) and the Integrated Development Plan (IDP).
• Accountable for end-to-end program leadership, including formally representing the program internally and externally, instigating innovation in early-stage development processes, issuing recommendations, making decisions to ensure the program success and asset value optimization, and ultimately propelling the program through preliminary testing and approval stages.
• Uphold regulatory compliance and meet initial stage commitments regarding prototype quality, timeline, projected cost, and potential value. Candidly communicate program impact projections and assess the early-stage commercial viability.

• Empower the team through clear roles/responsibilities, prioritizing individual growth, and holding team accountable for ambitious goals.
• Nurture a well-performing team that fosters collaboration and supportive challenge.

• Maintain positive relationships with stakeholders, ensuring clear, concise communication throughout the program lifecycle, and handle conflicts diplomatically.
• Build positive relationships with stakeholders; provide clear, concise communication about preliminary venture details and expertly navigate any arising conflicts.
• Enhance stakeholder understanding of program objectives/risks, influence their expectations through scientific and evidence-based communication, and involving stakeholders in decision-making processes. Adjust strategies based on stakeholders' needs, expectations, and potential responses.
• Foster stakeholders' understanding of project aims and inherent risks during initial development, shape their expectations through scientific evidence-based dialogue, and include them in decision-making processes. Adapt strategies by anticipating stakeholders concerns, needs, and possible responses.

Qualifications

• MD preferred or PhD with strong scientific background
• Experience in Immunology is required
• Min 8 years of drug development experience, including experience in dossier submission for new or supplemental indication
• Exposure to full drug development lifecycle
• Managing cross-functional teams and intense cross-functional collaboration and alignment
• Leading teams through influence without direct authority
• Communicating clearly and concisely with various audiences, adjusting messaging, style, tone, and details to best fit different audiences
• Experience in forming and driving transformative visions and strategic plans for early-stage programs.
• Background in team management, developing roles, and fostering a high-performance culture.
• Previous interactions with early stage/scientific stakeholders, emphasizing clear communication and involvement in decision-making.
• Experience in anticipating and crafting adaptive, resilient strategies for early-stage innovation and scenario planning.